IVERMECTIN DOES NOT REDUCE RISK OF SEVERE COVID



Standard of Care (SOC):
Based on the current Malaysian guidelines, standard of care for mild to moderate Covid-19 patients includes isolation, infection control, close monitoring (clinical findings, laboratory tests, chest imaging) and symptomatic treatment.

Study Population: 
The population for this clinical trial comprised of adults with a polymerase chain reaction (PCR) confirmed diagnosis of COVID-19 admitted to any of the participating hospitals.

Treatment Groups: 
(1) Ivermectin 0.4mg/kg/day for 5 days + Standard-of-Care
(2) Control group: Standard-of-Care only

Comments

Popular posts from this blog

UNITED STATES v. BOLA TINUBU (CASE # 1:93-cv-04483)

YOU CAN’T LOVE NIGERIA & WANT BOLA TINUBU AS ITS PRESIDENT

FACT CHECK: DID BOLA TINUBU CALL FOR REDUCTION OF NIGERIANS’ PURCHASING POWER?